Polysubstituted 2-aryl-6-phenylimidazo[1,2-A]pyridine derivatives, and preparation and therapeutic use thereof

1. A compound of formula (I):

wherein:

R 1 represents a phenyl group or a naphthyl group, wherein these two groups are optionally substituted with one or more atoms or groups chosen, independently of one another, from the following atoms or groups: halogen, (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, (C 1 -C 10 )thioalkyl, —S(O)(C 1 -C 10 )alkyl, —S(O) 2 (C 1 -C 10 -alkyl), hydroxyl, cyano, nitro, hydroxy(C 1 -C 10 )alkylene, NRaRb(C 1 -C 10 )alkylene, (C 1 -C 10 )alkoxy(C 1 -C 10 )alkylenoxy, NRaRb, CONRaRb, SO 2 NRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcC(O)ORe, NRcSO 2 Re, aryl(C 1 -C 10 )alkylene, monocyclic heteroaryl and aryl, wherein the monocyclic heteroaryl or aryl are optionally substituted with one or more substituents chosen from a halogen, and a (C 1 -C 10 ) alkyl, halo (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, oxo, nitro, cyano or OCO(C 1 -C 10 )alkyl group;

X represents from 1 to 4 substituents, which are identical to or different from one another, chosen from hydrogen, halogen, (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, NRaRb, cyano and nitro, wherein the (C 1 -C 10 )alkyl is optionally substituted with one or more groups chosen from a halogen, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb or hydroxyl;

R represents, at position 3, 5, 7 or 8 of the imidazo[1,2-a]pyridine, from 1 to 4 substituents, which are identical to or different from one another, chosen from a halogen, (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl and (C 1 -C 10 )alkoxy;

R 2 and R 3 represent, independently of one another,

a hydrogen atom;

a (C 1 -C 10 )alkyl group, optionally substituted with an Rf group; or

an aryl group, optionally substituted with one or more substituents chosen from a halogen, and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro or cyano group;

R 2 and X can form, together with the carbon atoms which bear them, a carbon-based ring containing from 5 to 7 carbon atoms;

R 4 represents:

a hydrogen atom;

a (C 1 -C 10 )alkyl group, optionally substituted with an Rf group; or

an aryl group, optionally substituted with one or more substituents chosen from a halogen, and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro, cyano, (C 1 -C 10 )alkyl(CO)—, CONRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcC(O)ORe or aryl group, the aryl being optionally substituted with one or more substituents chosen from a halogen, and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro or cyano group;

Ra and Rb represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group;

or Ra and Rb form, together with the nitrogen atom which bears them, an azetidine, pyrrolidine, piperidine, azepine, morpholine, thiomorpholine, piperazine or homopiperazine group, this group being optionally substituted with a (C 1 -C 10 )alkyl, aryl or aryl(C 1 -C 10 )alkylene group;

Rc and Rd represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group,

or Rc and Rd together form a (C 2 -C 5 )alkylene group;

Re represents a (C 1 -C 10 )alkyl, aryl(C 1 -C 10 )alkylene or aryl group,

or Rc and Re together form a (C 2 -C 5 )alkylene group; and

Rf represents a halogen atom, or a (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, hydroxyl, cyano, NRaRb, C(O)NRaRb, NRcCORd, OC(O)NRaRb, OCO(C 1 -C 10 )alkyl, NRcCOORe, SO 2 NRaRb, NRcSO 2 Re, aryl(C 1 -C 10 )alkylene or aryl group, wherein the aryl is optionally substituted with one or more substituents chosen from a halogen, and a (C 1 -C 10 )alkyl, halo(C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy, halo(C 1 -C 10 )alkoxy, NRaRb, hydroxyl, nitro, cyano or OCO(C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

2. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group or a naphthyl group, optionally substituted with one or more atoms or groups chosen, independently of one another, from halogen atoms or (C 1 -C 10 ) alkyl, (C 1 -C 10 ) alkoxy and halo (C 1 -C 10 )alkoxy groups;

or an acid addition salt thereof.

3. The compound of formula (I) according to claim 1 , wherein:

X represents 1 or 2 substituent(s), which are identical to or different from one another, chosen from hydrogen and halogen atoms;

or an acid addition salt thereof.

4. The compound of formula (I) according to claim 1 , wherein:

R represents, at position 3, 7 or 8 of the imidazo[1,2-a]pyridine, 1 or 2 substituent(s), which are identical to or different from one another, chosen from halogen atoms and (C 1 -C 10 )alkyl groups;

or an acid addition salt thereof.

5. The compound of formula (I) according to claim 1 , wherein:

R 2 and R 3 represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

6. The compound of formula (I) according to claim 1 , wherein:

R 4 represents a hydrogen atom or a (C 1 -C 10 )alkyl group;

or an acid addition salt thereof.

7. The compound of formula (I) according to claim 1 , wherein:

the group

 is at position 2, 3 or 4 on the phenyl nucleus which bears it;

or an acid addition salt thereof.

8. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group or a naphthyl group, optionally substituted with one or more atoms or groups chosen, independently of one another, from halogen atoms or (C 1 -C 10 )alkyl, (C 1 -C 10 ) alkoxy or halo (C 1 -C 10 )alkoxy groups;

X represents 1 or 2 substituent(s), which may be identical to or different from one another, chosen from hydrogen and halogen atoms;

R represents, at position 3, 7 or 8 of the imidazo[1,2-a]pyridine, a substituent chosen from halogen atoms and (C 1 -C 10 )alkyl groups;

R 2 and R 3 represent, independently of one another, a hydrogen atom or a (C 1 -C 10 )alkyl group;

R 4 represents a hydrogen atom or a (C 1 -C 10 )alkyl group; and

the group

 is at position 2, 3 or 4 on the phenyl nucleus which bears it; or an acid addition salt thereof.

9. The compound of formula (I) according to claim 1 , wherein:

R 1 represents a phenyl group or a naphthyl group, wherein these two groups are optionally substituted with one or more atoms or groups chosen, independently of one another, from the following atoms or groups: halogen, (C 1 -C 10 )alkyl, (C 1 -C 10 )alkoxy and halo(C 1 -C 10 )alkoxy;

X represents a hydrogen atom,

R is at position 3, 7 or 8 of the imidazo[1,2-a]pyridine and represents a (C 1 -C 10 )alkyl;

R 2 and R 3 represent, independently of one another, a hydrogen atom; and

R 4 represents a hydrogen atom;

or an acid addition salt thereof.

10. A compound selected from the group consisting of:

{3-[2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

{3-[2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

[3-(3-methyl-2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

{3-[2-(2,4-difluorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol and the hydrochloride thereof;

{3-[2-(4-chloro-3-methylphenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol and the hydrochloride thereof;

{3-[2-(4-chlorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol and the hydrochloride thereof;

{3-[2-(4-methoxyphenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol and the hydrochloride thereof;

{3-[2-[4-(difluoromethyloxy)phenyl]-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol and the hydrochloride thereof;

[3-(8-methyl-2-naphthyl-2-ylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

[4-(8-methyl-2-naphthyl-2-ylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

2-[3-(3-methyl-2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]propan-2-ol;

2-{3-[2-(4-chlorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}propan-2-ol;

2-{3-[2-(3-chlorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}propan-2-ol;

2-{3-[2-(2,4-difluorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}propan-2-ol;

2-{3-[2-(4-methoxyphenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}propan-2-ol;

{2-fluoro-6-[2-(4-methoxyphenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]phenyl}methanol;

[2,6-difluoro-3-(3-methyl-2-phenylimidazo[1,2-a]pyridin-6-yl)phenyl]methanol;

{3-[2-(4-chlorophenyl)-3-methylimidazo[1,2-a]pyridin-6-yl]-2,6-difluorophenyl}methanol;

{3-[2-(3-chlorophenyl)-3-methylimidazo[1,2-c]pyridin-6-yl]-2,6-difluorophenyl}methanol;

{2,6-difluoro-3-[2-(4-methoxyphenyl)-3-methylimidazo[1,2-c]pyridin-6-yl]-phenyl}methanol;

{3-[3-chloro-2-(4-chlorophenyl)imidazo[1,2-c]pyridin-6-yl]phenyl}methanol;

2-{3-[2-(4-chlorophenyl)-3-fluoroimidazo[1,2-c]pyridin-6-yl]phenyl}propan-2-ol;

2-{3-[3-chloro-2-(4-chlorophenyl)imidazo[1,2-c]pyridin-6-yl]phenyl}propan-2-ol;

[2-fluoro-6-(3-methyl-2-phenylimidazo[1,2-c]pyridin-6-yl)phenyl]methanol;

{2-[2-(4-chlorophenyl)-3-methylimidazo[1,2-c]pyridin-6-yl]-6-fluorophenyl}methanol;

{2-[2-(3-chlorophenyl)-3-methylimidazo[1,2-c]pyridin-6-yl]-6-fluorophenyl}methanol;

{2-[2-(2,4-difluorophenyl)-3-methylimidazo[1,2-c]pyridin-6-yl]-6-fluorophenyl}methanol;

3-chloro-6-(3-methoxymethylphenyl)-2-(4-chlorophenyl)imidazo[1,2-c]pyridine; and

{3-[3-chloro-2-(4-chlorophenyl)imidazo[1,2-c]pyridin-6-yl]-2,6-difluorophenyl}methanol.

11. A pharmaceutical composition comprising a compound of formula (I) according to claim 1 or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

12. A pharmaceutical composition comprising a compound according to claim 10 or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.